HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury

B. K. Harvey, C. F. Chang, Y. H. Chiang, W. J. Bowers, M. Morales, B. J. Hoffer, Y. Wang, H. J. Federoff

研究成果: 雜誌貢獻文章同行評審

64 引文 斯高帕斯(Scopus)

摘要

Direct intracerebral administration of glial cell line-derived neurotrophic factor (GDNF) is neuroprotective against ischemia-induced cerebral injury. Utilizing viral vectors to deliver and express therapeutic genes presents an opportunity to produce GDNF within localized regions of an evolving infarct. We investigated whether a herpes simplex virus (HSV) amplicon-based vector encoding GDNF (HSVgdnf) would protect neurons against ischemic injury. In primary cortical cultures HSVgdnf reduced oxidant-induced injury compared to the control vector HSVlac. To test protective effects in vivo, HSVgdnf or HSVlac was injected into the cerebral cortex 4 days prior to, or 3 days, after a 60-min unilateral occlusion of the middle cerebral artery. Control stroke animals developed bradykinesia and motor asymmetry; pretreatment with HSVgdnf significantly reduced such motor deficits. Animals receiving HSVlac or HSVgdnf after the ischemic insult did not exhibit any behavioral improvement. Histological analyses performed 1 month after stroke revealed a reduction in ischemic tissue loss in rats pretreated with HSVgdnf. Similarly, these animals exhibited less immunostaining for glial fibrillary acidic protein and the apoptotic marker caspase-3. Taken together, our data indicate that HSVgdnf pretreatment provides protection against cerebral ischemia and supports the utilization of the HSV amplicon for therapeutic delivery of trophic factors to the CNS.

原文英語
頁(從 - 到)47-55
頁數9
期刊Experimental Neurology
183
發行號1
DOIs
出版狀態已發佈 - 9月 1 2003
對外發佈

ASJC Scopus subject areas

  • 神經內科
  • 發展神經科學

指紋

深入研究「HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury」主題。共同形成了獨特的指紋。

引用此